10 Questions
What is the primary endpoint of the PIERCE study?
change in inspiratory capacity by +214mL
What was the median duration of follow-up in the UK Biobank study?
11.9 years
What is the website for more information on exciting career opportunities in Aotearoa New Zealand?
What improvement in lung function did ANORO Ellipta offer vs. Spiolto Respimat?
Up to 1.4x superior improvement
How many adults were included in the UK Biobank cohort for the air pollution study?
265,506
What was the improvement in tele-expiratory volume after bronchoscopic lung volume reduction using endobronchial valves in the PIERCE study?
-713mL
What was identified as the strongest association with different trajectories of chronic lung multimorbidity in the UK Biobank study?
fine particulate matter
What was the primary therapeutic target identified in the study mentioned in the text?
airway smooth muscle density
What unique benefit from ICSs was experienced by the subgroup identified in the study?
improved FEV1, reduced FeNO, and gas trapping
What was the difference in FEV1 after 12 months between triple therapy and dual therapy in participants with an airway smooth muscle cell area of >20%?
183.0 mL/year
Take the "Breathlessness and Respiratory Health Quiz" to test your knowledge on respiratory conditions, diagnosis delays, and patient frustrations. Explore the impact of premature diagnoses and the importance of effective communication between patients and healthcare providers.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
